Phototoxic and Photoallergic Potential of Tazarotene Foam 0.1% in 2 Phase 1 Patch StudiesNovember 1, 2012AcneContact DermatitisAesthetic Dermatology
Cumulative Irritation Potential and Contact Sensitization Potential of Tazarotene Foam 0.1% in 2 Phase 1 Patch StudiesOctober 1, 2012AcneContact Dermatitis
Therapeutic Modalities for Localized Psoriasis: 308-nm UVB Excimer Laser Versus Nontargeted PhototherapySeptember 1, 2012Psoriasis
Randomized, Observer-Blind, Split-Face Study to Compare the Irritation Potential of 2 Topical Acne Formulations Over a 14-Day Treatment PeriodAugust 1, 2012Acne
Antipruritic Hydrogel for the Treatment of Atopic Dermatitis: An Open-Label Pilot StudyAugust 1, 2012Contact Dermatitis
A Multicenter, Double-blind Study to Evaluate the Efficacy and Safety of 2 Treatments in Participants With Mild to Moderate Acne VulgarisJune 1, 2012Acne
What Is the Role of Field-Directed Therapy in the Treatment of Actinic Keratosis? Part 2: Commonly Used Field-Directed and Lesion-Directed TherapiesJune 1, 2012Actinic Keratosis
What Is the Role of Field-Directed Therapy in the Treatment of Actinic Keratosis? Part 1: Overview and Investigational Topical AgentsMay 1, 2012Actinic Keratosis
Clobetasol Propionate Spray 0.05% for the Treatment of Moderate to Severe Plaque PsoriasisFebruary 1, 2012Psoriasis
Once-Daily Application of Calcipotriene 0.005%–Betamethasone Dipropionate 0.064% Ointment for Repigmentation of Facial VitiligoNovember 1, 2011Pigmentation Disorders
An Open-label, Multicenter Study of the Efficacy and Safety of a Weekday/Weekend Treatment Regimen With Calcitriol Ointment 3 μg/g and Clobetasol Propionate Spray 0.05% in the Management of Plaque PsoriasisOctober 1, 2011Contact DermatitisPsoriasis
Evaluating the Efficacy and Safety of Calcipotriene/Betamethasone Ointment Occluded With a Hydrogel Patch: A 6-Week Bilaterally Controlled, Investigator-Blinded TrialSeptember 1, 2011Psoriasis
Comparative Evaluation of Men's Depilatory Composition Versus Razor in Black MenAugust 1, 2011Hair & Nails
Aluminum Chloride Hexahydrate in a Salicylic Acid Gel Base: A Case Series of Combination Therapy With Botulinum Toxic Type A for Moderate to Severe HyperhidrosisJuly 1, 2011
